AbCellera Biologics Inc
ABCLHealthcare|Biotechnology|Canada
$6.79
-0.49 (-6.72%)
DCF (FCF)
$1.87
Tangible Book
$2.81
Upcoming Data Readouts (2)
Feb 2027
Est. completion
P1P2Vasomotor Symptoms Associated With Menopause
Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause
NCT07118891n=136
Apr 2027
Est. completion
P1Healthy Volunteers
A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants
NCT07108894n=40